Categories AlphaGraphs, Earnings, Health Care
BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of 2023.
Total revenue declined 5% year-over-year to $2.46 billion. For the full year of 2023, the company expects revenues to decline in the mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.
Net income attributable to Biogen Inc. was $591.6 million or $4.07 per share in Q2, compared to $1.06 billion or $7.24 per share last year. Adjusted earnings declined 23% to $4.02 per share.
Prior Performance
Most Popular
Accenture (ACN) to report Q2 2025 results Thursday. Here’s what to expect
Accenture plc, (NYSE: ACN) is preparing to publish its second-quarter results this week, amid expectations for a year-over-year increase in revenue and profit. The professional services company had a strong
What to expect when Dollar Tree (DLTR) reports Q4 2024 earnings results
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) gained over 1% on Monday. The stock has dropped 6% over the past three months. The discount store chain is scheduled to report
MU Earnings Preview: Strong Q2 results in cards amid growing AI demand
Micron Technology, Inc. (NASDAQ: MU) is uniquely positioned to capitalize on the AI wave sweeping the tech industry, leveraging its high-bandwidth-memory products designed for massive data processing tasks. The company
